BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
4.205
+0.005 (0.12%)
Apr 25, 2025, 4:00 PM EDT - Market closed
BioAge Labs Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for BioAge Labs stock have an average target of 5.67, with a low estimate of 5.00 and a high estimate of 7.00. The average target predicts an increase of 34.84% from the current stock price of 4.21.
Analyst Consensus: Hold
* Price targets were last updated on Mar 24, 2025.
Analyst Ratings
The average analyst rating for BioAge Labs stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 2 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +18.91% | Mar 24, 2025 |
| Morgan Stanley | Morgan Stanley | Sell Initiates $5 | Sell | Initiates | $5 | +18.91% | Mar 7, 2025 |
| William Blair | William Blair | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Feb 28, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $45 → $7 | Strong Buy → Hold | Downgrades | $45 → $7 | +66.47% | Dec 9, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $42 → $7 | Strong Buy → Hold | Downgrades | $42 → $7 | +66.47% | Dec 9, 2024 |
Financial Forecast
Revenue This Year
n/a
from 1.70M
Revenue Next Year
n/a
EPS This Year
-2.18
from -6.63
EPS Next Year
-2.42
from -2.18
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | 7.0M | 7.0M |
| Avg | n/a | 1.7M | 1.7M |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | 311.8% |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.59 | -1.24 | -1.48 |
| Avg | -2.18 | -2.42 | -2.61 |
| Low | -2.89 | -3.03 | -3.44 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.